Ranibizumab in Residual Diabetic Macular Edema Following Previous Anti-VEGF Therapy
Status:
Completed
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
This study is designed to confirm that the investigational drug Ranibizumab given by
injection into the eye is safe and effective to use in people with diabetic macular edema
(DME).